UCB Strengthens Research Capabilities With Acquisition of Element Genomics, a Duke University Biotech Spin-off
Brussels (ots/PRNewswire) - - Acquisition to strengthen UCB's genomics and epigenomics research platform to identify novel drug targets UCB announces the acquisition of Element Genomics, a small-size biotech spin-off from Duke University, based in Durham, North Carolina (USA). The total cost of the transaction, ...
mehr